HealthDay News May 5, 2016 A device mounted onto eyeglasses enables people considered legally blind to “read” and perform other day-to-day activities, according to researchers.The device, called OrCam, features a miniature camera with optical character-recognition technology. The camera deciphers text and then “reads” it to the user through an earpiece. The device can even be […]
Mini-camera on glasses helps blind people ‘read’ Read More »
TUESDAY, March 1, 2016 There’s just not enough good data to say whether or not seniors should be routinely screened for vision trouble by their primary care physicians, an influential panel of U.S. experts reports.The U.S. Preventive Services Task Force (USPSTF) believes current data isn’t adequate to assess the potential benefits and harms of such
Experts Undecided on Whether Seniors Should Get Routine Vision Checks Read More »
MONDAY, Feb. 29, 2016 People with diabetes are at risk for blurred vision or even a loss of vision from a condition called macular edema.Three drugs for the disease — Avastin, Eylea and Lucentis vary widely in price, but new research suggests all work equally well for patients with mild vision loss.However, when diabetic macular
Study Compares Drugs for Common Diabetic Eye Disease Read More »
1. Take a 20-Second Computer Break. Staring at a computer (or any digital screen) won’t hurt your eyes, but it can make them feel tired and dry. Surprisingly, we blink about half as often when we’re looking at a screen. Follow the 20/20/20 rule: Every 20 minutes, look at least 20 feet away for at
Tips for Healthier Eyes Read More »
Drug Lucentis May Fight Diabetic Eye DiseaseGovernment-funded study finds injected medicine beats laser therapyNov. 13, 2015 (HealthDay News)The injected drug Lucentis (ranibizumab) appears highly effective at treating proliferative diabetic retinopathy, a common diabetes-related eye disease, new research shows.Investigators say the drug beat a standard treatment, laser therapy.The findings, “provide crucial evidence for a safe and
Lucentis May Fight Diabetic Eye Disease Read More »
Health Day NewsThe U.S. Food and Drug Administration on March, 2015Â approved the use of Eylea, an injected drug, to treat diabetic retinopathy in patients with diabetic macular edema.According to the U.S. Centers for Disease Control and Prevention, diabetic retinopathy is a leading cause of blindness in American adults. A third of those over 40 with
New FDA Drug for Diabetes Eye Condition Read More »
Eylea has slight advantage over Avastin, Lucentis for people with macular edema, but cost is an issue. WebMD News from HealthDayBy Robert PreidtHealthDay ReporterWEDNESDAY, Feb. 18, 2015 (HealthDay News) — A vision-robbing condition called diabetic macular edema can strike people with diabetes.Now, a new study compared three leading drugs for the condition — Avastin, Eylea
Study Compares Drugs for Diabetes Linked Eye Disease Read More »
